1-7 of 7
Dennis Cooper, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Dose Escalation Study of PT-112 in Patients with Relapsed or Refractory Multiple Myeloma

Taxiarchis Kourelis, MD, Sikander Ailawadhi, Dan T. Vogl, MD, Dennis Cooper, MD, Tyler D Ames, PhD, Christina Y Yim, PhD, Matthew R Price, Jose J Jimeno, MD PhD, P. Leif Bergsagel, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-134916
Published: 2020
Journal Articles

Reduction of Clostridium Difficile Infection in an Academic Medical Center Blood and Marrow Transplant Population

Brandi Handel, MSN, RN, Nicole McEntee, BSN, RN, OCN, BMTCN, Anne Tyno, RN, MSN, APN-C, Patricia Andrews, BSN, RN, OCN, Patricia Lafaro, BS, RN, CIC, Vimal Patel, MD, Dale G Schaar, MD PhD, Roger Strair, MD PhD, Dennis Cooper, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-142972
Published: 2020
Journal Articles

REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Deepu Madduri, MD, Ashley Rosko, MD, Jason Brayer, PhDMD, Jeffrey Zonder, William I. Bensinger, MD, Jingjin Li, PhD, Linzhi Xu, PhD, Lieve Adriaens, PharmD, Dhruti Chokshi, BS, Weijiang Zhang, PhD, Anita Boyapati, PhD, Manish Sharma, MD, Frank Seebach, MD, L. Andres Sirulnik, MD PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Madhav V. Dhodapkar, MD, Suzanne Lentzsch, MD PhD, Dennis Cooper, MD, Sundar Jagannath, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-139192
Published: 2020
Journal Articles

Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution Study

Dennis Cooper, MD, Jackie Manago, RN, BSN, Vimal Patel, MD, Dale Schaar, MD PhD, Tracy Krimmel, AOCN, APRN-BC, Mary Kate McGrath, RN, APN, Anne Tyno, RN, MSN, APN-C, Roger Strair, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4485.
https://doi.org/10.1182/blood-2019-130598
Published: 2019
Journal Articles

Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Dennis Cooper, MD, Deepu Madduri, MD, Suzanne Lentzsch, MD PhD, Sundar Jagannath, Jingjin Li, PhD, Anita Boyapati, PhD, Lieve Adriaens, PharmD, Dhruti Chokshi, BS, Min Zhu, PhD, Israel Lowy, MD PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Manish Sharma, MD, Maria Karasarides, PhD, David Sternberg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3176.
https://doi.org/10.1182/blood-2019-126818
Published: 2019
Journal Articles

Narcotic Use in Multiple Myeloma Patients at the Time of ASCT and One-Year Follow up

Matthew Danish, MD MS, Tabitha Copeland, MD, Joseph Ho, MD, Mansi Shah, MD BA, Dennis Cooper, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4726.
https://doi.org/10.1182/blood-2019-131551
Published: 2019
Journal Articles

Should All Patients with Acute Myelogenous Leukemia (AML) Other Than Good Risk Cytogenetics Receive Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Remission?

Onder Alpdogan, MD, Raymond Lenox, APRN, Amy Barile, APRN, Francine Foss, MD, Warren Shlomchik, MD, Christy Reuben, APRN, Dennis Cooper, MD, Stuart Seropian, MD
Journal: Blood
Blood (2008) 112 (11): 4396.
https://doi.org/10.1182/blood.V112.11.4396.4396
Published: 2008